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INSTRUCTIONS TO AUTHORS
The Journal of Dental Sciences (JDS) is the official peer-
reviewed and SCI-indexed journal of the Association for 
Dental Sciences of the Republic of China. The Journal is 
also indexed in ScienceDirect, SCOPUS, SIIC Data Bases 
and EMCare, and is published quarterly by Elsevier.
Authors are welcome to submit original contributions 
on clinical and laboratory research in the dental sciences 
and related fields.
The Editorial Board requires authors to be in 
compliance with the Uniform Requirements for 
Manuscripts Submitted to Biomedical Journals (URMs), 
which are compiled by the International Committee of 
Medical Journal Editors (ICMJE); current URMs are 
available at http://www.icmje.org. 
These Instructions to Authors are revised periodically 
by the Editors as needed. Authors should visit www.e-
jds.com for the latest version of these instructions. Any 
manuscript not prepared according to these instructions 
will be returned immediately to the author(s) without 
review.
1. Manuscript Submission
1.1. Online Submission
Manuscripts (meaning all submission items, including all 
text, tables, artwork, cover letter, conflicts of interest 
disclosures, and any other required documents/
material) must be submitted online to the JDS through 
the Elsevier Editorial System (EES) at http://ees.
elsevier.com/jds. This site will guide authors stepwise 
through the submission process. If assistance is required, 
please refer to the tutorials for authors and/or customer 
support that are available on the EES website; you may 
also contact the Editorial Office. Please do not post, fax 
or e-mail your manuscripts to the Editorial Office.
Editorial Office
Council on Publication
Association for Dental Sciences of the Republic of China
3F, No. 36, Hengyang Road, Taipei 10045, Taiwan, R.O.C.
Tel: (+886) (0)2 2311-6001
Fax: (+886) (0)2 2311-6080
E-mail: JDS@ads.org.tw
1.2. Important Information
•	 Articles	 should	 be	 in	 Microsoft	 Word	 document	
format and prepared in the simplest form possible. 
We	will	add	in	the	correct	font,	font	size,	margins	
and so on according to the Journal’s style.
•	 You	may	use	automatic	page	numbering,	but	do	NOT 
use other kinds of automatic formatting such as 
footnotes, headers and footers. References especially 
should	 NOT	 be	 formatted	 using	 the	 MS	 Word	
“endnotes” or “footnotes” function; instead, you may 
use the commercially available EndNote® or Reference 
Manager® software to manage your references.
•	 Put	text,	references,	table	headings	and	tables,	and	
figure legends in one file.
•	 Figures	must	be	submitted	as	separate	picture	files,	
at the correct resolution and named according to the 
figure number and format, e.g., “Fig1.tif”, “Fig2.
jpg”. Please see Section 9.8. for more information.
1.3. Supporting Documents
The following documents must be included in your 
submission (refer also to the Checklist that is available 
at www.e-jds.com). Items (1), (2) and (3) are mandatory. 
Items (4), (5), (6) and (7) are required only if they are 
applicable to your manuscript.
(1) Cover Letter. This must include the following 
information: 
•	 title	of	the	manuscript
•	 corresponding	 author	 details	 (name,	 e-mail,	
mailing address, telephone and fax numbers)
•	 a	 statement	 that	 the	material	 contained	 in	 the	
manuscript has not been previously published and 
is not being concurrently submitted elsewhere
•	 persons	who	do	not	 fulfill	 the	 requirements	 to	
be listed as authors but who nevertheless 
contributed to the manuscript (such as those 
who provided writing assistance, for example) 
should be disclosed
•	 list	 of	 manuscripts	 that	 have	 been	 published,	
submitted, or are in press that are similar to the 
submission to the JDS (and include in your 
submission copies of those similar manuscripts 
so that JDS Editors can be assured there is no 
overlap)
•	 your	signature	and	those	of	ALL	your	coauthors
•	 Optional: if you have a list of reviewers who you 
wish to review or not to review your manuscript, 
you may include this list in the cover letter
(2) Authorship & Conflicts of Interest Statement. Each 
author’s contribution to the manuscript should be 
listed. Any and all potential and actual conflicts of 
interest should also be listed (see Section 2 for more 
information). Please use the JDS Authorship & 
Conflicts of Interest Statement form that is provided 
on	 the	 Journal’s	 website	 at	 www.e-jds.com.	 Your	
signature and those of ALL your coauthors must be 
included.
(3) Copyright Transfer Agreement. In the event that 
your manuscript is accepted for publication in the 
JDS, you are required to transfer all copyright 
ownership in and relating to the work to the 
Association for Dental Sciences of the Republic of 
China. Please use the JDS Copyright Transfer 
Agreement form that is provided on the Journal’s 
website	at	www.e-jds.com.	Your	signature	and	those	
of ALL your coauthors must be included.
(4) Ethics Statement. Articles covering the use of human 
or animal samples in research, or human or animal 
experiments must be accompanied by a letter of 
approval from the relevant review committee or 
authorities. See Section 3 for more information.
(5) Consolidated Standards of Reporting Trials 
(CONSORT)	 flow	 chart	 for	 randomized	 controlled	
trials submitted for publication. See Section 4 for 
more information.
(6) Signed Statement of Informed Consent. Articles where 
human subjects can be identified in descriptions, 
photographs or pedigrees must be accompanied by a 
signed statement of informed consent to publish (in 
print and online) the descriptions, photographs and 
pedigrees from each subject who can be identified. 
See Section 5 for more information.
(7) Copyright Permission. If you have reproduced or 
adapted material from other copyrighted sources, 
the letter(s) of permission from the copyright 
holder(s) to reproduce or adapt the copyrighted 
sources must be supplied. Otherwise, such material 
must be removed from your manuscript.
2. Disclosure of Conflicts of Interest
A conflict of interest occurs when an individual’s 
objectivity is potentially compromised by a desire for 
financial gain, prominence, professional advancement 
or a successful outcome. JDS Editors strive to ensure 
that what is published in the Journal is as balanced, 
objective and evidence-based as possible. Since it can 
be difficult to distinguish between an actual conflict of 
interest and a perceived conflict of interest, the Journal 
requires authors to disclose all and any potential 
conflicts of interest.
Conflicts of interest may be financial or non-financial. 
Financial conflicts include financial relationships such as 
honoraria; educational grants; participation in speakers’ 
bureaus; membership, employment, consultancies, 
stock ownership, or other equity interest; expert 
testimony or patent-licensing arrangements. Non-
financial conflicts include personal or professional 
relationships, affiliations, academic competition, 
intellectual passion, knowledge or beliefs that might 
affect objectivity.
Please ensure that the name of each author listed in 
your manuscript appears in either Section I or Section II 
on page 2 of the JDS Authorship & Conflicts of Interest 
Statement form (an author’s name cannot appear in 
both Section I and Section II of the form).
3.  Ethical Approval of Studies and Informed 
Consent
For human or animal experimental investigations, 
appropriate institutional review board or ethics 
committee approval is required, and such approval 
should be stated in the methods section of the 
manuscript. For those investigators who do not have 
formal ethics review committees, the principles 
outlined in the Declaration of Helsinki should be 
followed	 (World	 Medical	 Association. Declaration of 
Helsinki: ethical principles for medical research 
involving human subjects. Available at: www.wma.net/
en/30publications/10policies/b3/17c.pdf).
For investigation of human subjects, state explicitly in 
the methods section of the manuscript that informed 
consent was obtained from all participating adult subjects 
and from parents or legal guardians for minors or 
incapacitated adults, together with the manner in which 
informed consent was obtained (e.g., oral or written).
For work involving animals, the guidelines for their care 
and use that were followed should be stated in the methods 
section of the manuscript. For those investigators who do 
not have formal institutional guidelines relating to animal 
experiments, the European Commission Directive 86/609/
EEC for animal experiments (available at http://ec.
europa.eu/environment/chemicals/lab_animals/
legislation_en.htm) should be followed and the same 
should be stated in the methods section of the manuscript.
4. Reporting Clinical Trials
All	randomized	controlled	trials	submitted	for	publication	
should include a completed Consolidated Standards of 
Reporting Trials (CONSORT) flow chart (please go to 
www.consort-statement.org for more information). The 
JDS has adopted the ICMJE proposal that requires, as a 
condition of consideration for publication of clinical 
trials, registration in a public trials registry. Trials must 
register at or before the onset of patient enrolment. The 
clinical trial registration number should be included at 
the end of the abstract of the article.
For this purpose, a clinical trial is defined as any 
research study that prospectively assigns human 
participants or groups of humans to one or more health-
related interventions to evaluate the effects of health 
outcomes. Health-related interventions include any 
intervention used to modify a biomedical or health-
related outcome (for example drugs, surgical 
procedures, devices, behavioral treatments, dietary 
interventions, and process-of-care changes). Health 
outcomes include any biomedical or health-related 
measures obtained in patients or participants, including 
pharmacokinetic measures and adverse events.
Purely observational studies (those in which the 
assignment of the medical intervention is not at the 
discretion of the investigator) will not require registration. 
Further information can be found at www.icmje.org.
5.  Identification of Patients in Descriptions, 
Photographs and Pedigrees
A signed statement of informed consent to publish (in 
print and online) patient descriptions, photographs and 
pedigrees should be obtained from all persons (parents 
or legal guardians for minors) who can be identified 
(including by the patients themselves) in such written 
descriptions, photographs or pedigrees. Such persons 
should be shown the manuscript before its submission. 
Omitting data or making data less specific to de-identify 
patients is acceptable, but changing any such data is not 
acceptable. State explicitly in the methods section of 
the manuscript that informed consent was obtained 
from all participating adult subjects or from parents or 
legal guardians for minors or incapacitated adults, 
together with the manner in which informed consent 
was obtained (i.e., oral or written).
6.  Previous Publication or Duplicate 
Submission
Submitted manuscripts are considered with the 
understanding that they have not been published 
previously in print or electronic format (except in abstract 
or poster form) and are not under consideration in totality 
or in part by another publication or electronic medium.
7. Basic Criteria
Articles should be written in English, using American 
English spelling, and meet the following basic criteria: 
the material is original, the information is important, 
the writing is clear and concise, the study methods are 
appropriate, the data are valid, and the conclusions are 
reasonable and supported by the data.
8. Article Categories
The categories of articles that are published in the 
Journal are listed and described below. Please select 
the category that best describes your paper. If your 
paper does not fall into any of these categories, please 
contact the Editorial Office.
8.1. Perspectives
These are comments on recent news or groundbreaking 
work and should provide a short review of the current 
state of research and explain the importance of the new 
findings. Perspectives on papers previously published in 
the JDS should add a different viewpoint to the research 
and should not merely be a repetitive summary of the 
original paper. Although many of the Perspectives 
published in the Journal are normally invited, unsolicited 
Perspectives are welcome and will be given due 
consideration.
As these are meant to express a personal commentary, 
with rare exceptions, Perspectives should have no more 
than 3 authors. The text should not exceed 1000 words, 
with no more than 1 figure or table, and no more than 
10 references.
8.2. Review Articles
These should aim to provide the reader with a balanced 
overview of an important and topical issue in research 
or clinical practice. They should cover aspects of a topic 
in which scientific consensus exists as well as aspects 
that remain controversial and are the subject of ongoing 
scientific research. All articles and data sources 
reviewed should include information about the specific 
type of study or analysis, population, intervention, 
exposure, and tests or outcomes. All articles or data 
sources should be selected systematically for inclusion 
in the review and critically evaluated.
The maximum length is 3500 words, and the number 
of references should not exceed 100.
8.3. Original Articles
These	 articles	 typically	 include	 randomized	 trials,	
intervention studies, studies of screening and diagnostic 
tests, laboratory and animal studies, cohort studies, 
cost-effectiveness analyses, case-control studies, and 
surveys with high response rates, which represent new 
and significant contributions to the field.
Section headings should be: Abstract, Introduction, 
Materials and methods, Results, Discussion, Conflicts of 
interest statement, Acknowledgments (if any), and 
References.
The Introduction should provide a brief background 
to the subject of the paper, explain the importance of 
the study, and state a precise study question or purpose.
The Materials and methods section should describe 
the study design and methods (including the study 
setting and dates, patients/participants with inclusion 
and exclusion criteria, patient samples or animal 
specimens used, the essential features of any 
interventions, the main outcome measures, the 
laboratory methods followed, or data sources and how 
these were selected for the study), and state the 
statistical procedures employed in the research.
The Results section should comprise the study results 
presented in a logical sequence, supplemented by tables 
and/or figures. Take care that the text does not repeat 
data that are presented in tables and/or figures. Only 
emphasize	and	summarize	the	essential	features	of	the	
main results.
The	Discussion	section	should	be	used	to	emphasize	
the new and important aspects of the study, placing the 
results in context with published literature, the 
implications of the findings, and the conclusions that 
follow from the study results.
The maximum length is 2500 words, and the number 
of references should not exceed 40.
8.4. Case Reports*
These are short discussions of a case or case series with 
unique features not previously described that make an 
important teaching point or scientific observation. They 
may describe novel techniques or use of equipment, or 
new information on diseases of importance. Section 
headings should be: Abstract, Introduction, Case report, 
Discussion, Conflicts of interest statement, 
Acknowledgments (if any), and References.
The Introduction should describe the purpose of the 
present report, the significance of the disease and its 
specificity, and briefly review the relevant literature.
The Case report should include statements of the 
problem, patient history, diagnosis, treatment, outcome 
and any other information pertinent to the case(s).
The	Discussion	should	compare,	analyze	and	discuss	
the similarities and differences between the reported 
case and similar cases reported in other published arti-
cles. The importance or specificity of the case should be 
restated when discussing the differential diagnoses. 
Suggest the prognosis of the disease and possibility of 
prevention.
Case reports should have no more than 6 authors. 
The maximum length is 1500 words, and the number of 
references should not exceed 10.
*The JDS is currently not accepting any submis-
sions of Case Reports due to the large number of as 
yet unpublished but accepted Case Reports. Once this 
backlog of Case Reports has been cleared, the Editors 
will reassess the situation. Please watch this space for 
further updates.
8.5. Short Communications
These reports should be concise presentations of 
preliminary experimental results, instrumentation and 
analytical techniques, or aspects of clinical or 
experimental practice that are not fully investigated, 
verified or perfected but which may be of widespread 
interest or application. The Editors reserve the right to 
decide what constitutes a Short Communication.
Short communications should have no more than 6 
authors. The abstract should be no longer than 150 
words. The main body of the text should not exceed 
1500 words, with no more than 2 tables or figures. The 
number of references should not exceed 10.
8.6. Research Letters
These typically include interesting cases that do not 
meet the requirement of being truly exceptional. The 
maximum length is 1000 words, and the number of 
references should not exceed 10.
8.7. Correspondence
These include short case reports, technical or clinical 
notes and short comments on previously published 
articles. The number of authors should not exceed 4. 
The text should not exceed 500 words and may include 1 
table or figure and up to 5 references. The Editors 
reserve the right to decide what constitutes a 
Correspondence.
8.8. Letters to the Editor
Brief letters of constructive comments in response to 
previously published JDS articles are welcome. Letters 
should have a title, no more than 3 authors, be no longer 
than 250 words, may include 1 table or figure and up to 
4 references. Ensure that the corresponding author’s 
mailing and e-mail addresses are included. Letters are 
edited, sometimes extensively, to sharpen their focus. 
They may be sent for peer review at the discretion of 
JDS Editors. Letters are selected based on clarity, 
significance, and space.
9. Manuscript Preparation
Text should be typed double-spaced on white A4 (297  
210 mm) paper, with outer margins of 2.5 cm. The 
manuscript should include a title page, abstract, text, 
conflicts of interest statement (if any), acknowledgments 
(if any), references, and figures and tables as 
appropriate. Each section of the manuscript should 
begin on a new page. Pages should be numbered 
consecutively, beginning with the title page.
9.1. Title Page
The title page should contain the following information 
(in order, from the top to bottom of the page):
•	 article	category
•	 article	title
•	 names	 (spelled	 out	 in	 full)	 of	 all	 authors*,	 and	 the	
institutions with which they are affiliated†; indicate all 
affiliations with a superscripted lowercase letter after 
the author’s name and in front of the matching affiliation
•	 corresponding	author	details	(name,	e-mail,	mailing	
address, telephone and fax numbers)
•	 running	title	not	exceeding	50	characters
*The name of each author should be written with the 
family name last, e.g., Wan-Lin Chang, and authorship 
is restricted only to direct participants who have 
contributed significantly to the work; †each author may 
list a maximum of 3 affiliations only.
9.2. Abstract and Keywords
An abstract (no longer than 300 words) and 3—5 relevant 
keywords (in alphabetical order) are required for the 
following article categories: Review Articles, Original 
Articles, Case Reports and Short Communications.
Abstracts for Review Articles, Case Reports and Short 
Communications should be unstructured (in one single 
paragraph with no section headings), and include 
information on the background/purpose of the report, 
methods, results (or case report), and conclusions.
Abstracts for Original Articles should be structured 
into the following sections.
•	 Background/purpose: briefly explain the importance 
of the study topic and state a precise study question 
or purpose.
•	 Materials and methods: briefly introduce the methods 
used to perform the study; include information on the 
study design, setting, subjects, interventions, 
outcome measures and analyses as appropriate.
•	 Results: briefly present the significant results, with 
data and statistical details such as P values where 
appropriate; be sure that information in the abstract 
matches that in the main text.
•	 Conclusion: state the meaning of your findings, being 
careful to address the study question directly and to 
confine your conclusions to aspects covered in the 
abstract; give equal emphasis to positive and 
negative findings.
Keywords should be taken from the Medical Subject 
Headings (MeSH) list of Index Medicus (www.nlm. 
nih.gov/mesh/meshhome.html).
No abstract or keywords are required for Perspectives, 
Research Letters, Correspondence and Letters to the 
Editor.
9.3. Main Text
The text for Original Articles and Short Communications 
should	 be	 organized	 into	 the	 following	 sections:	
Introduction, Materials (or Patients) and methods, 
Results, Discussion, Conflicts of interest statement, 
Acknowledgments (if any), and References. Subheadings 
in long papers are acceptable if needed for clarification 
and ease of reading. Sections for Case Reports are: 
Introduction, Case report, Discussion, Conflicts of 
interest statement, Acknowledgments (if any), and 
References. Each section should begin on a new page.
9.3.1. Abbreviations
Where	 a	 term/definition	will	 be	 continually	 referred	
to, it must be written in full when it first appears in 
the text, followed by the subsequent abbreviation in 
parentheses. Thereafter, the abbreviation may be 
used. An abbreviation should not be first defined in 
any section heading; if an abbreviation has previously 
been defined in the text, then the abbreviation may 
be used in a subsequent section heading. Restrict the 
number of abbreviations to those that are absolutely 
necessary and ensure consistency of abbreviations 
throughout the article. Ensure that an abbreviation so 
defined does actually appear later in the text 
(excluding in figures/tables), otherwise, it should be 
deleted.
9.3.2. Numbers
Numbers that begin a sentence or those that are less 
than 10 should be spelled out using letters. Centuries 
and decades should be spelled out, e.g., the Eighties or 
nineteenth century. Laboratory parameters, time, 
temperature, length, area, mass, and volume should be 
expressed using digits.
9.3.3. Units
Système International (SI) units must be used, with the 
exception of blood pressure values which are to be 
reported in mmHg. Use the metric system for the 
expression of length, area, mass, and volume. 
Temperatures are to be given in degrees Celsius.
9.3.4. Names of drugs, devices and other products
Use the Recommended International Non-proprietary 
Name (rINN) for medicinal substances, unless the specific 
trade name of a drug is directly relevant to the discussion. 
Generic drug names should appear in lowercase letters 
in the text. If a specific proprietary drug needs to be 
identified, the brand name may appear only once in the 
manuscript in parentheses following the generic name 
the first time the drug is mentioned in the text.
For devices and other products, the specific brand or 
trade name, the manufacturer and their location (city, 
state, country) should be provided the first time the 
device or product is mentioned in the text, for example, 
“…SPSS version 11 was used (SPSS Inc., Chicago, IL, 
USA)”. Thereafter, the generic term (if appropriate) 
should be used.
9.3.5. Gene nomenclature
Current standard international nomenclature for genes 
should be adhered to. For human genes, use genetic 
notation and symbols approved by the HUGO Gene 
Nomenclature	 Committee	 (www.genenames.org).	 You	
may also refer to the resources available on PubMed at 
www.ncbi.nlm.nih.gov/guide/genes-expression. The 
Human Genome Variation Society has a useful site that 
provides guidance in naming mutations at www.hgvs.org/
mutnomen/index.html. In your manuscript, genes should 
be typed in italic font and include the accession number.
9.3.6. Statistical requirements
Statistical analysis is essential for all research papers 
except Case Reports. Use correct nomenclature for 
statistical methods (e.g., two sample t test, not 
unpaired t test). Descriptive statistics should follow the 
scales used in data description. Inferential statistics are 
important for interpreting results and should be 
described in detail.
All P values should be presented to the third decimal 
place for accuracy. The smallest P value that should be 
expressed is P 	 0.001	 since	 additional	 zeros	 do	 not	
convey useful information; the largest P value that 
should be expressed is P  0.99.
9.3.7. Personal communications and unpublished data
These sources cannot be included in the references list 
but may be described in the text. The author(s) must 
give the full name and highest academic degree of the 
person, the date of the communication, and indicate 
whether it was in oral or written (letter, fax, e-mail) 
form. A signed statement of permission should be 
included from each person identified as a source of 
information in a personal communication or as a source 
for unpublished data.
9.4. Conflicts of Interest Statement and/or 
Funding/Support Statement
Since it is difficult to distinguish between an actual conflict 
of interest and a perceived conflict of interest, the JDS 
requires authors to disclose all and any potential conflicts 
of interest and let readers judge for themselves. Therefore, 
please ensure that you provide information about any 
potential financial and non-financial conflicts of interest 
(see Section 2 for more information) in a concise paragraph 
after the main text. If none, then state "The author(s) have 
no conflicts of interest relevant to this article."
All financial and material support for the research, 
work, writing and editorial assistance from internal or 
external agencies, including commercial companies, 
should be clearly and completely identified in a Funding/
Support Statement.
9.5. Acknowledgments
After the Conflicts of Interest Statement and/or Funding/
Support Statement, general acknowledgments for 
consultations and statistical analyses should be listed 
concisely, including the names of the individuals who 
were directly involved. Consent should be obtained from 
those individuals before their names are listed in this 
section. Those acknowledged should not include 
secretarial, clerical or technical staff whose participation 
was limited to the performance of their normal duties.
9.6. References
Authors are responsible for the accuracy and 
completeness of their references and for correct in-text 
citation. If massive corrections to the references are 
found to be necessary in the event that your manuscript 
is accepted, JDS Editors reserve the right to rescind the 
accept decision and reject the article.
9.6.1. In the main text, tables and figure legends
•	 References	 should	 be	 indicated	 by	 superscripted	
numbers according to order of appearance in the 
text, and placed after punctuation. [The actual 
authors can be referred to, but the reference 
number(s) must always be given.]
•	 References	cited	in	tables	or	figure	legends	should	be	
included in sequence at the point where the table or 
figure is first mentioned in the main text.
•	 Do	 not	 cite	 abstracts	 unless	 they	 are	 the	 only	
available reference to an important concept.
•	 Do	not	cite	uncompleted	work	or	work	that	has	not	
yet been accepted for publication (i.e., “unpublished 
observation”, “personal communication”) as 
references. Also see Section 9.3.7.
9.6.2. In the references list
•	 References	 should	 be	 compiled	 at	 the	 end	 of	 the	
manuscript according to the order of citation in the 
text.
•	 References	 should	 be	 limited	 to	 those	 cited	 in	 the	
text only.
•	 Journal	references	should	include,	in	order,	authors’	
surnames and initials, article title, abbreviated 
journal name, year, volume and inclusive page 
numbers.
•	 The	surnames	and	initials	of	all	the	authors	up	to	6	
should be included, but when authors number 7 or 
more, list the first 3 authors only followed by “et al”.
•	 Abbreviations	 for	 journal	 names	 should	 conform	 to	
those used in MEDLINE.
•	 If	citing	a	website,	provide	the	author	 information,	
article title, website address and the date you 
accessed the information.
•	 Reference	to	an	article	that	is	in	press	must	state	the	
journal name and, if possible, the year and volume.
Examples of the most common reference types are 
provided below. (Please pay particular attention to the 
formatting,	word	capitalization,	spacing	and	style.)
Standard journal articles
Lin	 SS,	 Lai	 JP,	 Yen	 YY,	 Chen	 IC,	 Kuo	 AH,	 Yeh	 IC.	
Investigation into the prediction accuracy of 
photocephalometry for skeletal Class III adult female 
patients treated with two-jaw surgery. J Dent Sci 
2012;7:137—47.
Napoli C, Trerotoli P, Solinas G, et al. Caries experience 
among adolescents in southeast Italy. J Dent Sci 
2012;7:89—93.
Journal supplement
Kaplan NM. The endothelium as prognostic factor and 
therapeutic target: what criteria should we apply? J 
Cardiovasc Pharmacol 1998;32(Suppl 3):S78—80.
Journal article not in English but with English abstract
Hofele C, Schwager-Schmitt M, Volkmann M. Prognostic 
value of antibodies against p53 in patients with oral 
squamous cell carcinoma—five years survival rate. 
Laryngorhinootologie 2002;81:342—5. [In German, 
English abstract]
Book with edition
Bradley EL. Medical and Surgical Management, 2nd ed. 
Philadelphia: Saunders, 1982.
Book with editors
Letheridge S, Cannon CR, eds. Bilingual Education: 
Teaching English as a Second Language.	 New	 York:	
Praeger, 1980.
Book chapter in book with editor and edition
Greaves M, Culligan DJ. Blood and bone marrow. In: 
Underwood JCE, ed. General and Systematic Pathology, 
4th ed. London: Churchill Livingstone, 2004:615—72.
Book series with editors
Wilson	JG,	Fraser	FC,	eds.	Handbook of Teratology, Vols. 
1—4.	New	York:	Plenum	Press,	1977—1978.
Bulletin
World	Health	Organization.	World Health Report 2002: 
Reducing Risk, Promoting Healthy Life. Geneva, 
Switzerland:	World	Health	Organization,	2002.
Electronic publications
Duchin JS. Can preparedness for biological terrorism 
save us from pertussis? Arch Pediatr Adolesc Med 
2004;158(2). Available at http://archpedi.ama-assn.
org/cgi/content/full/158/2/106. [Date accessed: June 
12, 2004]
Smeeth L, Iliffe S. Community screening for visual 
impairment in the elderly. Cochrane Database Syst Rev 
2002(2):CD001054. Doi:10.1002/14651858.CD1001054.
Item presented at a meeting but not yet published
Khuri FR, Lee JJ, Lippman SM. Isotretinoin effects on 
head and neck cancer recurrence and second primary 
tumors. In: Proceedings from the American Society of 
Clinical Oncology, May 31–June 3, 2003, Chicago, IL, 
abstract 359.
Item presented at a meeting and published
Cionni RJ. Color perception in patients with UV- or 
bluelight-filtering IOLs. In: Symposium on Cataract, IOL, 
and Refractive Surgery. San Diego, CA: American Society 
of Cataract and Refractive Surgery, 2004, abstract 337.
Thesis
Ayers AJ. Retention of Resin Restorations by Means of 
Enamel Etching and by Pins. MSD thesis, Indiana 
University School of Dentistry, Indianapolis, 1971.
Website
American Association of Oral and Maxillofacial 
Surgeons. Wisdom Teeth. Rosemont, IL: AAOMS, 2008. 
Available at: http://www.aaoms.org/wisdom_teeth.php 
[Date accessed: November 15, 2008]
Company/manufacturer publication/pamphlet
Eastman Kodak Company, Eastman Organic Chemicals. 
Catalog No. 49.	 Rochester,	 NY:	 Eastman	 Kodak,	
1977:2—3.
9.7. Tables
Tables should supplement, not duplicate, the text. 
They should have a concise table heading, be self-
explanatory, and numbered consecutively in the order 
of their citation in the text. Items requiring explanatory 
footnotes should be denoted using superscripted 
lowercase letters (a, b, c, etc.), with the footnotes 
arranged under the table in alphabetical order. 
Asterisks	(*,	**)	are	used	only	to	indicate	the	probability	
level of tests of significance. Abbreviations used in the 
table must be defined and placed after the footnotes 
in alphabetical order. If you include a block of data or 
table from another source, whether published or 
unpublished, you must acknowledge the original 
source.
9.8. Figures
9.8.1. General guidelines
The number of figures should be restricted to the 
minimum necessary to support the textual material. 
Figures should have an informative figure legend and be 
numbered in the order of their citation in the text. All 
symbols and abbreviations should be defined in the 
figure legend in alphabetical order. Items requiring 
explanatory footnotes should follow the same style as 
that for tables as described in Section 9.7.
Unless you have written permission from the patient 
(or, where applicable, the next of kin), the personal 
details (such as their name and date of birth) of the 
patient must be removed. If their face is shown, use a 
black bar to cover their eyes so that they cannot be 
identified (for further information, see www.elsevier.
com/patientphotographs).
All lettering should be done professionally and should 
be in proportion to the drawing, graph or photograph. 
Photomicrographs must include an internal scale marker, 
and the legend should state the type of specimen, 
original magnification and stain.
Figures must be submitted as separate picture files, 
at the correct resolution (see Section 9.8.2.) and named 
according to the figure number and format, e.g., “Fig1.
tif”, “Fig2.jpg”.
9.8.2. Formats
Regardless of the application used, when your electronic 
artwork	 is	 finalized,	 please	 “save	 as”	 or	 convert	 the	
images to one of the following formats (note the 
resolution requirements for line drawings, halftones, 
and line/halftone combinations given below).
•	 EPS:	 vector	 drawings.	 Embed	 the	 font	 or	 save	 the	
text as “graphics”.
•	 TIFF:	color	or	grayscale	photographs	(halftones)—use	
a minimum of 300 dpi.
•	 TIFF:	 bitmapped	 line	 drawings—use	 a	 minimum	 of	
1000 dpi.
•	 TIFF:	combination	of	bitmapped	line/halftone	(color	
or grayscale)—use a minimum of 600 dpi.
•	 DOC,	XLS	or	PPT:	if	your	electronic	artwork	is	created	
in any of these Microsoft Office applications, please 
supply “as is”.
Please do not:
•	 Supply	 files	 that	 do	 not	 meet	 the	 resolution	
requirements detailed above;
•	 Supply	files	that	are	optimized	for	screen	use	(such	
as	GIF,	BMP,	PICT,	WPG)	as	the	resolution	is	too	low;
•	 Submit	graphics	that	are	disproportionately	large	for	
the content.
A detailed guide on electronic artwork is available 
at www.elsevier.com/artworkinstructions. Please note 
that the cost of color illustrations will be charged to the 
author (see Section 12 for more information).
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author should contact the Editorial Office.
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be accepted if the author has not supplied all the 
material and documents as outlined in these author 
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Office via the EES within 60 days. Please notify the 
Editorial Office in advance if additional time is needed or 
if you choose not to submit a revised manuscript.
10.1. Pre-final Acceptance English Editing/
Polishing
Your	 manuscript	 should	 be	 edited	 and	 polished	 by	 a	
native English speaker before final acceptance. Authors 
should return the revised manuscript with a language 
editing/polishing certificate or authors may choose to 
use the English editing/polishing service provided by the 
Editorial Office. Please contact the Editorial Office if 
the service is required and for information on the 
charges. The Editorial Office reserves the right to 
rescind the accept decision if the manuscript does not 
undergo English editing/polishing.
11. Preparation for Publication
Once a manuscript has been accepted for publication 
and completed English editing/polishing, authors should 
submit	the	final	version	of	their	manuscript	in	MS	Word	
format, with all tables/figures as applicable, via the EES.
Accepted manuscripts are then presented to the 
Publisher to be copyedited according to the Journal’s 
style and the galley proofs in the form of a PDF file are 
sent by the Publisher to the corresponding author for 
final approval. Authors are responsible for all statements 
made in their work, including changes made by the copy 
editor.
Proofreading is solely the authors’ responsibility. 
Note that the Editorial Board reserves the right to make 
revisions to the manuscript and the Publisher may 
proceed with the publication of your article if no 
response from the author(s) is received.
11.1. Changes to Authorship
This policy concerns the addition, deletion, or rear-
rangement of author names in the authorship of 
accepted manuscripts. Before the accepted manuscript 
is published online, requests to add or remove an author, 
or to rearrange the author names, must be sent to the 
Journal Manager from the corresponding author of the 
accepted manuscript and must include: (i) the reason 
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author names, this must include confirmation from the 
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not sent by the corresponding author will be forwarded 
by the Journal Manager to the corresponding author, 
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Note that: (1) Journal Managers will inform the 
Journal Editors of any such requests and (2) online pub-
lication of the accepted manuscript is suspended until 
authorship has been agreed.
After the accepted manuscript is published online, 
any requests to add, remove, or rearrange author names 
in an article will follow the same policies as detailed 
above and result in a corrigendum.
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